Memantine and Naltrexone Treatment for Opioid Dependence
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to test the efficacy of memantine (a noncompetitive NMDA receptor
antagonist) as an adjunct to the maintenance treatment with naltrexone in detoxified
heroin-dependent individuals.